85 related articles for article (PubMed ID: 91053)
1. Theophylline-induced lomustine toxicity.
Zeltzer PM; Feig SA
Lancet; 1979 Nov; 2(8149):960-1. PubMed ID: 91053
[No Abstract] [Full Text] [Related]
2. Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
Hildebrand J; Gangji D; Nouwynck C; Machin D
Cancer Treat Rep; 1977 Dec; 61(9):1695-8. PubMed ID: 74284
[No Abstract] [Full Text] [Related]
3. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q
Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930
[TBL] [Abstract][Full Text] [Related]
4. 5-fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.
Tejada F; Eisenberger MA; Broder LA; Cohen MH; Simon R
Cancer Treat Rep; 1977 Nov; 61(8):1589-90. PubMed ID: 922761
[No Abstract] [Full Text] [Related]
5. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
6. Salvage chemotherapy for non-Hodgkin's lymphoma.
Ng PR; Todd D; Khoo RK
Cancer Treat Rep; 1982 Nov; 66(11):1977-9. PubMed ID: 7139640
[TBL] [Abstract][Full Text] [Related]
7. Lomustine treatment of metastatic renal cell carcinoma.
Mittelman A; Albert DJ; Murphy GP
JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
[No Abstract] [Full Text] [Related]
8. Fatal pulmonary toxic effects of lomustine.
Dent RG
Thorax; 1982 Aug; 37(8):627-9. PubMed ID: 7179192
[No Abstract] [Full Text] [Related]
9. [Hepatic damage during treatment with C.C.N.U].
de Labarthe B; Chahinian P; Gosselin M; Goasguen J; Ferrand B; Danrigal A; Israel L
Sem Hop Ther; 1975; 51(5-6):309-14. PubMed ID: 1224203
[No Abstract] [Full Text] [Related]
10. Pulmonary fibrosis associated with lomustine (CCNU): a case report.
Vats TS; Trueworthy RC; Langston CM
Cancer Treat Rep; 1982 Oct; 66(10):1881-2. PubMed ID: 7127329
[No Abstract] [Full Text] [Related]
11. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
[TBL] [Abstract][Full Text] [Related]
12. CCNU nephrotoxicity following sustained remission in oat cell carcinoma.
Silver HK; Morton DL
Cancer Treat Rep; 1979 Feb; 63(2):226-7. PubMed ID: 221116
[No Abstract] [Full Text] [Related]
13. [Hematopoiesis during combined treatment of lung cancer patients with cyclophosphan and nitrosomethylurea or CCNU].
Sokolova II; Trubnikova EN; Trakhtenberg AKh
Ter Arkh; 1980; 52(9):88-91. PubMed ID: 7434240
[No Abstract] [Full Text] [Related]
14. [Acute myelomonoblastic leukemia in renal cancer treated with CCNU. 4 cases in 29 patients].
Droz JP; Kebrat P; Bayle C; Ruffié P; Cukier J; Amiel JL
Presse Med; 1983 Feb; 12(5):305. PubMed ID: 6220399
[No Abstract] [Full Text] [Related]
15. [Progressive insufficiency after CCNU therapy].
Berglund J
Lakartidningen; 1980 Apr; 77(18):1760. PubMed ID: 7382694
[No Abstract] [Full Text] [Related]
16. 1-2(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): a comparison of drug administration at four-week and six-week intervals.
Broder LE; Hansen HH
Eur J Cancer (1965); 1973 Feb; 9(2):147-52. PubMed ID: 4717488
[No Abstract] [Full Text] [Related]
17. Visual abnormalities following nitrosourea treatment.
Louie AC; Turrisi AT; Muggia FM; Bono VH
Med Pediatr Oncol; 1978; 5(1):245-7. PubMed ID: 745590
[No Abstract] [Full Text] [Related]
18. Single agent palliative chemotherapy for end-stage Hodgkin's disease.
Mead GM; Harker WG; Kushlan P; Rosenberg SA
Cancer; 1982 Sep; 50(5):829-35. PubMed ID: 6178495
[No Abstract] [Full Text] [Related]
19. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 44-1978.
N Engl J Med; 1978 Nov; 299(19):1060-7. PubMed ID: 703773
[No Abstract] [Full Text] [Related]
20. Phase II of ACNU for non-small cell lung cancer.
Sasaki Y; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Sakurai M; Ishizuya Y; Fujita J; Futami H
Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1557-9. PubMed ID: 3868621
[No Abstract] [Full Text] [Related]
[Next] [New Search]
